Leroux B, Rose J P, Potron G, Grun G, Droulle C, Mesmin F, Gomes H
Nouv Presse Med. 1976 Mar 13;5(11):699-702.
The authors present the results obtained using a therapeutic combinaison of plasminogen-urokinase in vivo in 14 premature infants suffering from respiratory distress. 86 % survived, a considerable improvement over classical survival rates. In addition it appeared that the duration of oxygen therapy was shorter, secondary to limitation of extension of the disease.